Riskpilot← Back to searchSign inGet full accessObserve Medical AB
ABActiveOrg 5567232037Krokslätts Parkgata 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20073 employees
Revenue 2024
SEK 11,2M
+35% vs 2023
EBITDA margin
-72.5%
-10% vs 2023
Equity ratio
73.8%
Financial strength
Net profit 2024
SEK -7,3M
-2% vs 2023
| Revenue | SEK 11,2M | +35% |
| EBITDA | SEK -8,1M | -10% |
| Net profit | SEK -7,3M | -2% |
| Total assets | SEK 55,5M | -10% |
| Equity | SEK 41M | -15% |
| Employees | 3 | — |
Legal name
Observe Medical AB
Org number
5567232037
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8 februari 2007
Share capital
SEK 112 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva försäljning och utveckling av medicintekniska produkter samt därmed förenlig verksamhet.
Address
Krokslätts Parkgata 4
Phone
+46317411260
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 79 | 122 | 141 | 8 283 | 11 207 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −13 299 | −16 619 | −19 287 | −7 351 | −8 120 |
| Depreciation & amort. | −389 | −498 | −1 409 | −2 096 | −1 851 |
| EBIT | −13 688 | −17 117 | −20 696 | −9 447 | −9 971 |
| Net financials | −567 | 501 | 4 106 | 3 306 | 3 013 |
| Profit before tax | −14 237 | −16 617 | −16 591 | −7 166 | −7 331 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −14 237 | −16 617 | −16 591 | −7 166 | −7 331 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 057 | 14 498 | 64 780 | 61 641 | 55 498 |
| Equity | 20 695 | 4 079 | 55 464 | 48 298 | 40 968 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 361 | 10 419 | 9 316 | 13 343 | 14 530 |
| Total debt | 5 361 | 10 419 | 9 316 | 13 343 | 14 530 |
EBITDA margin
-72.5%
This company
15.8%
Market median
-559% vs market
20202024
Equity ratio
73.8%
This company
38.2%
Market median
+93% vs market
20202024
Return on equity
-17.9%
This company
18.4%
Market median
-197% vs market
20202024
Net profit margin
-65.4%
This company
8.1%
Market median
-907% vs market
20202024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JG Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
JM Chief Executive Officer | Chief Executive Officer | 2024 |
MM Chief Auditor | Chief Auditor | 2024 |
| Former (4) | ||
PM Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
MG Chief Auditor | Chief Auditor | 2020 – 2024 |
PA Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
EB External Signatory | External Signatory | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
| Former (4) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2020 | |
| Deputy Board Member | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OBSERVE MEDICAL ASA
Observe Medical AB (this company)Board members of Observe Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Magnus Emmoth | Chief Executive Officer | 0 companies |
| Jens-Oskar Göransson | Authorized Recipient of Service | 0 companies |
| Mattias Gustaf Erik Olofson | Chief Auditor | 0 companies |
| Jörgen Mann Nielsen | Chief Executive Officer | 0 companies |
| Malin Matilda Ekman Lorentzon | Chief Auditor | 0 companies |
| Per Arne Nygård | Chief Executive Officer | 0 companies |
| Eva Britt Nyberg | External Signatory | 0 companies |
| Björn Oskar Larsson | Board of Directors | 0 companies |
| Kathrine Gamborg Andreassen | Chairman | 0 companies |
| Toril Marie Ås | Board of Directors | 0 companies |
| Anna Jenny Wennerberg | Deputy Board Member | 0 companies |
| Terje Bakken | Board of Directors | 0 companies |